Brief: Verve Therapeutics reports Q2 results
09/08/2022 12:43
Aug 9 (Reuters) - Verve Therapeutics Inc VERV.O :
* VERVE THERAPEUTICS PROVIDES CORPORATE UPDATES AND REPORTS
SECOND
QUARTER 2022 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.84
* OVER $300 MILLION IN CAPITAL ADDED TO BALANCE SHEET,
SUPPORTING
AN OPERATING RUNWAY INTO SECOND HALF OF 2025
Source text for Eikon: ID:nGNX1rn6zs
Further company coverage: VERV.O